The studies are exploring new approaches to asthma treatment, including an investigational oral medication and a more environmentally friendly inhaler propellant.
Could you take part in the BREADTH Trial?
You could be part of an important clinical trial of an investigational oral pill that may help reduce the symptoms of asthma. The BREADTH Trial is looking for participants who:
- Are aged 18–75
- Have had asthma for at least one year
- Have tried asthma treatments but still experience uncontrolled symptoms
There is no cost to participate. You will be paid for your trial-related time and travel. The trial team can give you more details on this payment. To learn more, talk to your doctor or contact 0117 414 8114 or respiratoryresearch@nbt.nhs.uk.
Help test a more climate-friendly asthma inhaler in the TRECONY study
The TRECONY study is evaluating an investigational asthma inhaler that uses a new climate-friendly propellant designed to have a lower global warming potential.
We’re looking for adults with mild to moderate asthma who currently use a daily inhaled steroid at low or medium dose for asthma treatment (such as beclomethasone, budesonide, ciclesonide, fluticasone, or mometasone) associated or not with a bronchodilator.
The study lasts about 20 weeks and includes eight visits to the site. Study drugs, study visits and study-related tests and examinations are provided at no cost.
Find out more
Get in touch with the Southmead Respiratory Research team on 0117 414 8114 or respiratoryresearch@nbt.nhs.uk.